Navigation Links
Shanghai ChemPartner and ELARA Pharmaceuticals Expand Drug Discovery Collaboration to a New Level
Date:8/4/2009

SHANGHAI, Aug. 4 /PRNewswire-Asia/ -- Shanghai ChemPartner Co., Ltd., (ChemPartner) a wholly owned subsidiary of ShangPharma Corporation, announced today that it has moved its drug discovery collaboration with ELARA Pharmaceuticals to a new level. ChemPartner will provide fully integrated services in the areas of DMPK, pharmacology and toxicology for ELARA's lead oncology programs. Members of the joint project team from both sides will work closely together to design and execute a drug screening cascade.

"This new relationship is a natural result of the high quality services provided by ChemPartner," commented Dr. Joe Lewis, CEO and a founder of ELARA Pharmaceuticals. "The discovery support from ChemPartner helped our Hypoxia Signaling inhibitor program to move from academic discovery stage to early proof of concept. This led to a successful spin off from the European Molecular Biology Laboratory (EMBL) in Heidelberg, Germany. Our new integrated relationship will enable ELARA to further leverage ChemPartner's strong R&D capabilities from discovery to early development phase. We anticipate a stronger strategic partnership down the road as our program progresses."

"We are very pleased to see that our services helped ELARA turn innovative research at a renowned academic institution into a venture funded drug discovery company," said Michael Hui, founder and CEO of ChemPartner. "Our partnership demonstrates the strength of ChemPartner's innovation driven and fully integrated R&D service platform"

About Shanghai ChemPartner

Founded in 2003, Shanghai ChemPartner Company Ltd. (ChemPartner) is one of the leading contract research organizations providing medicinal chemistry, discovery biology, pharmacology, DMPK, toxicology, process R&D, analytical development, formulation and contract manufacturing services to over 80 pharmaceutical and biotech companies in the worl
'/>"/>

SOURCE Shanghai ChemPartner Co., Ltd.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Shanghai Century Acquisition Corporation Announces Sichuan Kelun Pharmaceutical Co Results for the Six Months Ended June 30, 2007
2. HUYA Bioscience International Licenses Clinical Stage Anti-Arrhythmic Compound from the Shanghai Institute of Materia Medica
3. Cinpathogen Brings Together Over 40 Shanghai Area Hospitals at the First Annual Cinpathogen Hematology Conference
4. Cinpathogen Provides Clinical Diagnostic Consulting Services to Shanghai Area Hospitals
5. Shanghai CRO Service Alliance Adds Clinical Development Capabilities
6. Carna Biosciences Signs Distribution Agreement with Shanghai Universal Biotech Company
7. Cynvec to Present at the 11th Annual Shanghai International Forum on Biotechnology and Pharmaceutical Industry
8. NeoStem Signs Agreement with Shanghai Corporation to Develop A Stem Cell Collection and Treatment Network in Shanghai, Taiwan and Other Targeted China Provinces
9. Sundia and 2 Other CRO Companies Granted Express Customs Clearance Privilege in Shanghai
10. Shanghai ChemPartner and Agios Expand Integrated Drug Discovery Research Collaboration
11. Sundia Shortens CRO Shipment Delivery Time with Express Customs Clearance in Shanghai

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...wswire/--BiotechfirmReplikinsLtd.,whichhasanalyzed...theprediction,outbreak,andprogressofthecurrentH1N1...thevirus.ThenewdatashowsthatthelethalityoftheH1N1(...)duringthevirus,scurrentoutbreakinthespringof2009t...heH1N1virus,infectivitycount,however,remainsincrea...
(Date:11/25/2009)...ewswire-Asia/--SinovacBiotechLtd.(SVA),aleadingde...xecuted,ajointventure(JV)agreementtoestablishSinov...).TheJVwillresearch,develop,produce,andcommerciali...ise,andexperienceindevelopingandcommercializingwor...rights,manufacturingfacilitiesand,establishedopera...
(Date:11/24/2009)...ewswire-FirstCall/--IES(Nasdaq: IESC ),aleadingnat...ndservicesforthecommercial,industrialandresidentia...ouphasbeenawardedacontractfromManhattanTorconJVtoi...b(BSL-4)replacementfacilityattheU.S.ArmyMedicalRes...DetrickinFrederick,Md. ,, ThenewUSAMRIIDreplace...
(Date:11/24/2009)...,Ontario,Nov.24/PRNewswire-FirstCall/--DowAgroScie...landSeeds,adivisionofThompsonsLimitedofBlenheim,On...AgroSciences,currentseedsbusinessasthecompanyantic...dDowAgroSciencesHerbicideTolerantTraitTechnologyin...rfuture. ,, "Thisacquisitionbringstogethertwost...
Breaking Biology Technology:Biological H1N1 Vaccines: Too Little, Too Late 2Biological H1N1 Vaccines: Too Little, Too Late 3Biological H1N1 Vaccines: Too Little, Too Late 4Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 2Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 3Integrated Electrical Services Awarded Contract to Provide Electrical Systems for U.S. Army Medical Research Institute of Infectious Diseases 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 3
... Multiporator / Electroporator 2510 , , ,... Transformation Protocol , Pr... , , , , , , , ,... Nocardia corallina, , ...am positive, , , Mo...
... Multiporator , , , , , , ...on Protocol , Protocol No. 4308 915.04..., , , , , , ,..., , , Cell type ,..., , Transformation with , ...
... Multiporator , , , , , , ... Protocol , Protocol No. 4308 915.036 ... , , , , , , ...rovascular endothelial cells from , r... , Transfection with , Plas...
Other Biology Technology:Nocardia corallina 2Neurospora crassa 2Primary cells, rat heart endothel 2
(Date:11/24/2009)... Springer and the American College of Medical Toxi...ate on the publication of the Journal of Medical ...T, beginning in March 2010. It was previously pub..., The Journal of Medical Toxicology , an interna...ancing the science and practice of medical toxicol...
(Date:11/24/2009)... This release is available in Spanish . , ...higher levels of inflammatory substances in the bl...ht; as shown by a research project of the Universi...o, a scientist at the School of Pharmacy. , The ... study in relation to the control of body weight a...
(Date:11/23/2009)..., A new study by the Wildlife Conservation Societ...arge swamp in the Republic of Congopart of the "mo...d last yearare becoming increasingly threatened by...udy recommends protection of the swamp forests adj...Reserve after recent surveys confirmed that high d...
Breaking Biology News(10 mins):Springer and the American College of Medical Toxicology to work together 2It can be predicted the reaction obese patients will have to a diet 2A year after discovery, Congo's 'mother lode' of gorillas remains vulnerable 2WuXi PharmaTech Announces Shareholder Resolutions Adopted at 2009 Annual General Meeting 13461 1WuXi PharmaTech Announces Shareholder Resolutions Adopted at 2009 Annual General Meeting 13461 2Research breakthrough will lead to more accurate weather forecasts 13460 1Research breakthrough will lead to more accurate weather forecasts 13460 2Mental Activity Seems to Keep the Brain Vital 54005 1Mental Activity Seems to Keep the Brain Vital 54005 2
... cells with the capacity to build fat, according t...l Cell, a Cell Press publication. Although they ...es, transplants of the progenitor cells isolated f...al fat tissue in animals that are otherwise lackin...ses of obesity, a condition characterized by an in...
...gy have shaped not only how we find or share infor...ect just funded by the National Institutes of Heal... next level. , The University of Michigan will le...data needed to develop computer programs that more... data will be housed in a Web-based resource that ...
...m the Herman B Wells Center for Pediatric Research...focusing on a family of blood proteins that they ...f chemotherapy in children and adults. , Their f...geted therapies for leukemia, multiple myeloma and...ed by Kristin T. Chun, Ph.D., assistant professor ...
Other Biology News:Fat-regenerating 'stem cells' found in mice 2New data resource to advance computer-aided drug design 2On the trail of a targeted therapy for blood cancers 2
GIBCO Newborn Calf Serum from Invitrogen
...d efficient removal of short primers, dNTPs, enzym...products (Figure 1). The simple PureLink bind/wash...tions for fragments >100 bp or >300 bp* , can be p...format , takes ,Two proprietary buffers are supp...
...nute cloning and subsequent sequencing of PCR prod...rimer sites located as close as 33 base pairs from...e amount of vector DNA that needs to be read befor... available. The pCR4-TOPO vector provides 3-T over...
Zebrafish Vitellogenin ELISA System from GE Healthcare, formerly Amersham Biosciences
Biology Products: